News from the FDA/CDC
FDA/CDC
FDA okays ubrogepant for acute migraine treatment
ACHIEVE I and ACHIEVE II demonstrate efficacy.
News from the FDA/CDC
FDA approves Dayvigo for insomnia
The orexin receptor antagonist will be available in 5-mg and 10-mg tablets after DEA scheduling.
News from the FDA/CDC
Vaping-linked lung injury: 2,172 cases, 42 deaths
Forty-two deaths from EVALI have been confirmed in 24 states and the District of Columbia.
News from the FDA/CDC
Fentanyl-related deaths show strong regional pattern
Overdose death rates for cocaine, heroin, and fentanyl are high in the East and low in the West.
Feature
President to nominate oncologist to lead FDA
President Trump has indicated his intent to nominate Stephen Hahn, MD, as FDA Commissioner.
News from the FDA/CDC
Suicide deaths rising in children aged 10-19 years
Death rate from suicide has nearly tripled for those aged 10-14 since 2007.
News from the FDA/CDC
CDC reports most vaping lung disease linked to THC-containing cartridges
Most vaping cartridges were obtained on the street, from dealers, online, or from friends or social contacts.
News from the FDA/CDC
CDC finds that too little naloxone is dispensed
Despite increases in the number of naloxone prescriptions dispensed, many patients at risk for overdose are not offered the potentially life-...
FDA/CDC
HHS proposes pathways for drug importation
Officials at the U.S. Department of Health and Human Services have announced a new plan that they say would lay the foundation for safe...
FDA/CDC
FDA approves first generics of pregabalin
The first generic approvals of the drug were granted to nine companies.
News from the FDA/CDC
Smoking-cessation attempts changed little over 7-year span
“Smokers should be encouraged to keep trying to quit until they succeed, and health care providers should be encouraged to keep supporting smokers...